Iranian Journal of Cancer Prevention. 2015; 8 (6): 35-40
in English
| IMEMR
| ID: emr-175790
ABSTRACT
Background:
The association between human papillomavirus [HPV] infections and cervical cancer has suggested the design of prophylactic and therapeutic vaccines against genital warts. The HPV capsid has made of two L1 and L2 coat proteins that have produced late in viral infections. Regarding to the recent studies, two commercial prophylactic vaccines have based on L1 viral like particles [VLPs] could strongly induce antibody responses, and protect human body from HPV infections. However, the use of these HPV vaccines has hindered due to their high cost and some limitations. Currently, among various vaccination strategies, live vector-based vaccines have attracted a great attention
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Oncogene Proteins, Viral
/
Capsid Proteins
/
Immunity, Humoral
/
Leishmania
/
Mice
/
Antibody Formation
Limits:
Animals
Language:
English
Journal:
Iran. J. Cancer Prevention
Year:
2015
Similar
MEDLINE
...
LILACS
LIS